Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

UPDATE: Senate Minority Leader Mitch McConnell Says Biden’s Budget Plan Falls Short On Defense Spending

-Reuters

byBenzinga Newsdesk

March 28, 2022

1 minute read

-Reuters

UNITY Biotechnology’s Investor And Analyst Day To Highlight UBX1325 Program In Age-Related Diseases Of The Eye October 12

By Benzinga Newsdesk

Today, 11:07 PM

- Presentations from UNITY's leadership team and fireside chat with retina expert Robert B. Bhisitkul, M.D., Ph.D., on Wednesday, October 12 from 8:00 a.m. to 9:30 a.m. ET - SOUTH SAN FRANCISCO, Calif., Oct.

UBX

Teleflex Recalls Percutaneous Thrombolytic Device Kits

By Vandana Singh

Today, 11:07 PM

Teleflex Incorporated (NYSE: TFX)

TFX

Merk Reports Positive CHMP Opinion For KEYTRUDA In Combo With Chemo for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1

By Benzinga Newsdesk

Today, 11:07 PM

Recommendation Based on Data From Phase 3 KEYNOTE-355 Trial KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the Committee for Medicinal Products

MRK

Q2 Growth ‘Nothing Short Of Virtuous’: Economist

By Sam Corey

Today, 11:07 PM

The coronavirus pandemic that began in 2020 and is persisting today has led many investors to hold poor market expectations. But maybe they shouldn’t be so pessimistic.

ARKG

UPDATE: Senate Minority Leader Mitch McConnell Says Biden’s Budget Plan Falls Short On Defense Spending

Related Posts

UNITY Biotechnology’s Investor And Analyst Day To Highlight UBX1325 Program In Age-Related Diseases Of The Eye October 12

Teleflex Recalls Percutaneous Thrombolytic Device Kits

Merk Reports Positive CHMP Opinion For KEYTRUDA In Combo With Chemo for Certain Patients With Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Whose Tumors Express PD-L1

Q2 Growth ‘Nothing Short Of Virtuous’: Economist